Breast Cancer

Herceptin's side effects

Published in Women's Health Weekly, May 30th, 2002

Around 30% of breast tumors contain cells that overexpress a protein called HER2/neu or ErbB2. The chemotherapy drug, Herceptin, blocks this protein and, as such, is highly effective in treating these types of cancer. It is widely used in the U.S. and some European countries, and was approved for use by the U.K. National Institute of Clinical Excellence (NICE) in March 2002.

Undeniably, Herceptin saves lives. However, the drug, made by Swiss company Roche and U.S. biotechnology firm Genentech, carries the warning that it may in some instances "result in the development of ventricular dysfunction and congestive heart failure" - conditions of cardiomyopathy. The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2002-05-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry